The use of a commercial TTF-1 antibody product demonstrated positive TTF-1 expression in 11 out of 12 lung adenocarcinoma cases, while one non-pulmonary adenocarcinoma case showed positive TTF-1 expression. The gene discussed is TTF1; the disease is lung adenocarcinoma.